nicotinamide mononucleotide has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, C; Do, Y; Fukahori, Y; Hirai, H; Kang, D; Miki, K; Nabeshima, YI; Setoyama, D; Toshima, T; Uchiumi, T; Yagi, M | 1 |
| Fujioka, H; Liao, X; Sangwung, P; Shen, Y; Zhang, L; Zhang, R; Zhou, L | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Cardiac Failure
| Article | Year |
|---|---|
Improving lysosomal ferroptosis with NMN administration protects against heart failure.
Topics: Animals; Ferroptosis; Heart Failure; Mice; Mitochondria; NAD; Nicotinamide Mononucleotide | 2023 |
Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure.
Topics: Acetylation; Animals; Cell Death; Fatty Acids; Heart Failure; Homeostasis; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Proteins; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidation-Reduction; Pressure; Rats; Reactive Oxygen Species; Sirtuin 3 | 2017 |